Skip to main content

Rehmann Capital Advisory Group

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1633037 LANSING, MI

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$910,495
+$32,337 QoQ
Shares Held
2,039
+5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Rehmann Capital Advisory Group holds $2,772,824 across 3 Biotechnology names. VRTX ranks #2 (32.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
2,039 $910,495

All Filings in VRTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $910,495 2,039
2025-12-31 $878,158 1,937
2025-09-30 $734,716 1,876
2025-06-30 $760,401 1,708
2025-03-31 $758,258 1,564
2024-12-31 $610,493 1,516
2024-09-30 $907,836 1,952
2024-06-30 $1,265,075 2,699
2024-03-31 $1,162,067 2,780
2023-12-31 $1,016,411 2,498
2023-09-30 $767,809 2,208
2023-06-30 $777,017 2,208
2023-03-31 $809,414 2,569
2022-12-31 $749,672 2,596
2022-09-30 $731,957 2,528
2022-06-30 $650,371 2,308
2022-03-31 $730,716 2,800
2021-12-31 $528,796 2,408
2021-09-30 $466,716 2,573
2021-06-30 $535,126 2,654
2021-03-31 $451,913 2,103
2020-12-31 $431,084 1,824
2020-09-30 $551,859 2,028
2020-06-30 $557,104 1,919
2020-03-31 $361,921 1,521